Classic Car Club Manhattan
18.1.2024 15:02:57 CET | ACCESS Newswire | Press release
Kavanagh, Former On and Off-Road Motorcycle Racer Is Ready to Meet the Challenge of Sustainable Racing in a Global Series
NEW YORK, NY / ACCESSWIRE / January 18, 2024 / Today, Team Blue Rising, co-owned by Indian cricket star Virat Kohli and sports tech entrepreneur Adi K. Mishra, has announced the signing of on and off-road motorcycle racer Phelim Kavanagh as its official pilot for the upcoming UIM E1 World Championship. The selection of Kavanagh will round out the Team Blue Rising pilot lineup for the 2024 season, where he will join fellow pilot Lisa Caussin Battaglia.
To view this piece of content from www.accesswire.com, please give your consent at the top of this page.Phelim Kavanagh, former motorcycle racer, recruited as official pilot for Team Blue Rising competing in the UIM E1 World Championship.
Born in London, Phelim Kavanagh's youth was dominated by rugby, which he played at an international level. Following his graduation, Kavanagh moved to New York, where he became a director at the famed auto club, Classic Car Club Manhattan. Through strategic partnerships with industry giants like Red Bull, Rivian, Lucid, McLaren, Bentley, Chopard and Gucci, the club has notably elevated its profile, hosting exclusive, high-profile events that underscore its standing as a premier destination among New York City's elite clubs. While in America, Phelim took up motorcycle racing both on and off-road. He quickly became a fierce competitor, having won many road races in the Champion Cup Series, as well as competing internationally in Red Bull Enduro Motorcycle Racing events.
"I'm very excited to join Team Blue Rising, where I can feed my love of competition and motorsport, whilst at the same time, having the opportunity to be part of a meaningful sustainability movement," said Kavanagh. "I'm very much looking forward to being a productive member of the team and racking up victories in the water."
Virat Kohli, co-owner of Team Blue Rising, expressed his enthusiasm about the new signing: "Adi & I are thrilled to onboard Phelim Kavanagh as the official male pilot of Team Blue Rising. His dedication and skill in motorsport are vital for our bold pursuit in the UIM E1 World Championship. We're looking forward to seeing him bring his unique talents to electric boat racing and help propel Team Blue Rising to new heights."
The UIM E1 World Championship is the world's first all-electric race boat series, where 8 teams from around the globe will compete in seven race weekends in Europe and the Middle East. The series has attracted luminary team owners from all walks of life, including Steve Aoki, Tom Brady, Marc Anthony and Sergio Perez to name a few.
X
Contact Information
Michael Prichinello
Communications
mikep@classiccarclub.com
2122292402
SOURCE: Team Blue Rising
To view this piece of content from stats.newswire.com, please give your consent at the top of this page.View the original press release on newswire.com.
To view this piece of content from www.accesswire.com, please give your consent at the top of this page.About ACCESS Newswire
Subscribe to releases from ACCESS Newswire
Subscribe to all the latest releases from ACCESS Newswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from ACCESS Newswire
Anew Climate Expands European Forest Carbon Portfolio Through Ten-Year Agreement with Sweden's EKEN1.10.2026 15:00:00 CEST | Press release
HOUSTON, TX / ACCESS Newswire / October 1, 2026 / Anew Climate (Anew), one of the world's largest developers and marketers of carbon credits, announced a ten-year agreement with EKEN Financing Value Added Forestry (EKEN) to bring Swedish improved forest management (IFM) credits to corporate buyers worldwide. The agreement extends Anew's European forest carbon portfolio, which it maintains alongside millions of acres of managed forestland across North America. Under the collaboration, Anew will serve as the exclusive commercialization partner for credits generated from projects developed by EKEN, handling purchaser engagements, structuring, and portfolio integration for corporate buyers in Europe and internationally. EKEN is preparing the project for development under VM0045, Verra's methodology for improved forest management using dynamic matched baselines from national forest inventories. While many conventional forest carbon baselines rest on a projection of what a landowner would hy
Karbon‑X (OTCQB:KARX) Reports Record Fiscal 2026 Revenue of $55.9 Million as Company Scales Global Carbon Market Operations1.10.2026 14:30:00 CEST | Press release
CALGARY, AB / ACCESS Newswire / October 1, 2026 / Karbon‑X Corp. (OTCQB:KARX) ("Karbon‑X" or the "Company"), a vertically integrated climate solutions company operating across global carbon markets, today reported financial and operational results for the fiscal year ended May 31, 2026, reflecting a significant increase in operating scale across its carbon credit trading and project development activities. Karbon‑X generated record fiscal 2026 revenue of $55.9 million, compared with $3.16 million in fiscal 2025, representing an increase of approximately 1,670% year over year. Gross profit was $0.86 million, compared with $0.80 million in the prior year. Fiscal 2026 results reflected a shift in revenue mix toward high-volume, lower-margin trading activity as Karbon‑X completed its first full year of large-scale carbon credit trading. "Fiscal 2026 moved Karbon-X into a new stage of commercial growth," said Chad Clovis, Chief Executive Officer of Karbon-X. "Revenue reached nearly eighteen
Surmodics Acquires Alta Biomed Business, Expanding Hemocompatible Surface Technology and Analytical Testing Capabilities1.10.2026 14:00:00 CEST | Press release
HORSHAM, PA / ACCESS Newswire / October 1, 2026 / Surmodics Inc., a leading provider of surface technologies and performance coatings for the medical device industry, today announced that it has acquired the business of Alta Biomed, a Carlsbad, California-based medical device coating and testing services company specializing in surface technologies for vascular and other medical devices. The acquisition is a strategic addition to Surmodics' growing portfolio of hemocompatible and biocompatible surface technologies. It brings Alta Biomed's proprietary PzF™ thin-film surface modification technology to Surmodics, adding an established anti-thrombotic, anti-inflammatory and pro-healing option that joins Surmodics' existing hemocompatible portfolio. "As medical device innovation advances in neuromodulation, brain-computer interfaces, neurovascular, structural heart, and venous and arterial technologies, engineers and scientists need a broader range of surface technology options to address i
PharmaNest and Mediar Therapeutics Collaborate to Quantify ECM and Fibrosis Remodeling in the EncompaSSc Phase 2 Trial of MTX-474 in Diffuse Cutaneous Systemic Sclerosis30.9.2026 19:00:00 CEST | Press release
PRINCETON, NJ / ACCESS Newswire / September 30, 2026 / PharmaNest, Inc. an AI-enabled digital pathology company specializing in the quantitative and spatial characterization of fibrosis and Mediar Therapeutics, Inc., a clinical-stage biotechnology company pioneering first-in-class therapies to halt and reverse fibrosis, today announced a collaboration to integrate advanced digital pathology into Mediar's ongoing EncompaSSc Phase 2 clinical trial of MTX-474 in patients with diffuse cutaneous systemic sclerosis (dcSSc). MTX-474 is a first-in-class human IgG1 monoclonal antibody designed to neutralize EphrinB2 signaling, a pathway implicated in myofibroblast activation, extracellular matrix (ECM) deposition and tissue remodeling known to drive fibrosis in SSc. The randomized, double-blind, placebo-controlled EncompaSSc Phase 2 study is evaluating the safety and efficacy of MTX-474 in patients with dcSSc. Under the collaboration, PharmaNest will apply its FibroNest™ AI-enabled digital path
Innodata Opens Motion-Capture AI Lab to Help Humanoids Move Like Humans30.9.2026 15:50:00 CEST | Press release
NEW YORK, NY / ACCESS Newswire / September 30, 2026 / Innodata Inc. (Nasdaq:INOD) today announced the opening of a new R&D laboratory that is designed to generate the data needed to train the next generation of human-like robots and independently validate the performance data that robots generate internally. Innodata developed the lab in collaboration with Vicon, a leader in motion capture who consulted on the lab design and continues to provide technical consulting. The New Jersey-based lab is equipped with high-precision, low-latency infrared optical tracking cameras that measure movement down to the sub-millimeter level-a degree of accuracy that methods such as wearable inertial measurement unit (IMU) sensors and single-camera (monocular) video analysis typically cannot match. The lab addresses an urgent need for high-quality training data for humanoids, industrial robots, and other forms of physical AI. While many other data providers infer 3D motion by analyzing 2D video, Innodata
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom